Evaluation of FIV protein-expressing VEE-replicon vaccine vectors in cats

Vaccine

Volumn 21, Issue 3-4, 2002, Pages 258-268

  Burkhard, Mary Jo ^a   Valenski, Loretta ^a   Leavell, Sarah ^a   Dean, Gregg A ^a   Tompkins, Wayne A F ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Feline immunodeficiency virus (FIV); VEE replicon particles; Venezuelan equine encephalitis (VEE) virus

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAG PROTEIN; L SELECTIN; VIRUS ENVELOPE PROTEIN; ENVELOPE PROTEIN, FELINE IMMUNODEFICIENCY VIRUS; GLYCOPROTEIN; RECOMBINANT VACCINE; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; CAT; CONTROLLED STUDY; CYTOLYSIS; EVALUATION; FELINE IMMUNODEFICIENCY VIRUS; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; REPLICON; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; ANIMAL; BIOSYNTHESIS; BLOOD; CAT DISEASE; CYTOTOXIC T LYMPHOCYTE; GENE VECTOR; GENETICS; IMMUNOLOGY; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VAGINA; VIREMIA; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; CATS; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; EVALUATION STUDIES; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; GENETIC VECTORS; GLYCOPROTEINS; IMMUNODEFICIENCY VIRUS, FELINE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; VACCINES, SYNTHETIC; VAGINA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES; VIREMIA;

EID: 0037073542     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00455-3     Document Type: Article

References (53)

1. Centers for Disease Control and Prevention: HIV/AIDS surveillance report. MMWR Morb Mortal Wkly Rep 1999;11:1-43.
2. Quinn T.C., Wawer M.J., Sewankambo N., Serwadda D., Li C., Wabwire-Mangen F.et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group [see comments]. N. Engl. J. Med. 342:2000;921-929.
3. Fiscus S.A., Vernazza P.L., Gilliam B., Dyer J., Eron J.J., Cohen M.S. Factors associated with changes in HIV shedding in semen. AIDS Res. Hum. Retroviruses. 14(1):1998;S27-S31.
4. Krieger J.N., Coombs R.W., Collier A.C., Ross S.O., Chaloupka K., Cummings D.K.et al. Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy. J. Infect. Dis. 163:1991;386-388.
5. Plummer F.A., Simonsen J.N., Cameron D.W., Ndinya-Achola J.O., Kreiss J.K., Gakinya M.N.et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1 [see comments]. J. Infect. Dis. 163:1991;233-239.
6. Zhu T., Wang N., Carr A., Nam D.S., Moor-Jankowski R., Cooper D.A.et al. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J. Virol. 70:1996;3098-3107.
7. Sodora D.L., Gettie A., Miller C.J., Marx P.A. Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Res. Hum. Retroviruses. 14(1):1998;S119-123.
8. Miller C.J. Mucosal transmission of simian immunodeficiency virus. Curr. Top. Microbiol. Immunol. 188:1994;107-122.
9. Burkhard M.J., Obert L.A., O'Neil L.L., Diehl L.J., Hoover E.A. Mucosal transmission of cell-associated and cell-free feline immunodeficiency virus. AIDS Res. Hum. Retroviruses. 13:1997;347-355.
10. Bucci J.G., English R.V., Jordan H.L., Childers T.A., Tompkins M.B., Tompkins W.A. Mucosally transmitted feline immunodeficiency virus induces a CD8+ antiviral response that correlates with reduction of cell-associated virus. J. Infect Dis. 177:1998;18-25.
11. Bishop S., Stokes C., Gruffydd-Jones T., Whiting C., Harbour D. Vaginal and rectal infection of cats with feline immunodeficiency virus. Vet. Micro. 51:1996;217-227.
12. Moench T.R., Whaley K.J., Mandrell T.D., Bishop B.D., Witt C.J., Cone R.A. The cat/feline immunodeficiency virus model for transmucosal transmission of AIDS: nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculum. Aids. 7:1993;797-802.
13. Biasin M., Caputo S.L., Speciale L., Colombo F., Racioppi L., Zagliani A.et al. Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative women. J. Infect. Dis. 182:2000;1365-1374.
14. Kaul R., Trabattoni D., Bwayo J.J., Arienti D., Zagliani A., Mwangi F.M.et al. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. Aids. 13:1999;23-29.
15. Kaul R., Plummer F.A., Kimani J., Dong T., Kiama P., Rostron T.et al. HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1- resistant prostitutes in Nairobi. J. Immunol. 164:2000;1602-1611.
16. Kaul R., Rowland-Jones S.L., Kimani J., Dong T., Yang H.B., Kiama P.et al. Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses. J. Clin. Invest. 107:2001;341-349.
17. Mazzoli S., Trabattoni D., Lo Caputo S., Piconi S., Ble C., Meacci F.et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals [see comments]. Nat. Med. 3:1997;1250-1257.
18. Rowland-Jones S.L., Dong T., Fowke K.R., Kimani J., Krausa P., Newell H.et al. Cytotoxic T-cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J. Clin. Invest. 102:1998;1758-1765.
19. Pushko P., Parker M., Ludwig G.V., Davis N.L., Johnston R.E., Smith J.F. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology. 239:1997;389-401.
20. Davis N.L., Caley I.J., Brown K.W., Betts M.R., Irlbeck D.M., McGrath K.M.et al. Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles. J. Virol. 74:2000;371-378.
21. Davis N.L., Brown K.W., Johnston R.E. A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge. J. Virol. 70:1996;3781-3787.
22. Caley I.J., Betts M.R., Irlbeck D.M., Davis N.L., Swanstrom R., Frelinger J.A.et al. Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector. J. Virol. 71:1997;3031-3038.
23. MacDonald G.H., Johnston R.E. Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis. J. Virol. 74:2000;914-922.
24. Balasuriya U.B., Heidner H.W., Hedges J.F., Williams J.C., Davis N.L., Johnston R.E.et al. Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles. J. Virol. 74:2000;10623-10630.
25. Burkhard M.J., Mathiason C.K., Bowdre T., Hoover E.A. Feline immunodeficiency virus Gag- and Env-specific immune responses after vaginal versus intravenous infection. AIDS Res. Hum. Retroviruses. 17:2001;1767-1778.
26. Gebhard D.H., Dow J.L., Childers T.A., Alvelo J.I., Tompkins M.B., Tompkins W.A. Progressive expansion of an L-selectin-negative CD8 cell with anti-feline immunodeficiency virus (FIV) suppressor function in the circulation of FIV-infected cats. J. Infect. Dis. 180:1999;1503-1513.
27. Reid G., Rigby M.A., McDonald M., Hosie M.J., Neil J.C., Jarrett O. Immunodiagnosis of feline immunodeficiency virus infection using recombinant viral p17 and p24. Aids. 5:1991;1477-1483.
28. de Parseval A., Elder J.H. Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor. J. Virol. 75:2001;4528-4539.
29. Diehl L.J., Mathiason-DuBard C.K., O'Neil L.L., Hoover E.A. Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a quantitative competitive reverse transcriptase PCR. J. Virol. 69:1995;2328-2332.
30. Rogers A.B., Hoover E.A. Maternal-fetal feline immunodeficiency virus transmission: timing and tissue tropisms. J. Infect Dis. 178:1998;960-967.
31. Kaul R., Dong T., Plummer F.A., Kimani J., Rostron T., Kiama P.et al. CD8+ lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J. Clin. Invest. 107:2001;1303-1310.
32. Zimmerman C., Brduscha-Riem K., Blaser C., Zinkernagel R.M., Pircher H. Visualization, characterization, and turnover of CD8+ memory T-cells in virus-infected hosts. J. Exp. Med. 183:1996;1367-1375.
33. Hamann D., Baars P.A., Rep M.H., Hooibrink B., Kerkhof-Garde S.R., Klein M.R.et al. Phenotypic and functional separation of memory and effector human CD8+ T-cells. J. Exp. Med. 186:1997;1407-1418.
34. Bucci J.G., Gebhard D.H., Childers T.A., English R.V., Tompkins M.B., Tompkins W.A. The CD8+ cell phenotype mediating antiviral activity in feline immunodeficiency virus-infected cats is characterized by reduced surface expression of the CD8 beta chain. J. Infect. Dis. 178:1998;968-977.
35. Landay A.L., Mackewicz C.E., Levy J.A. An activated CD8+ T-cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin. Immunol. Immunopathol. 69:1993;106-116.
36. Mackewicz C., Levy J.A. CD8+ cell anti-HIV activity: nonlytic suppression of virus replication. AIDS Res. Hum. Retroviruses. 8:1992;1039-1050.
37. Mackewicz C.E., Yang L.C., Lifson J.D., Levy J.A. Non-cytolytic CD8+ T-cell anti-HIV responses in primary HIV-1 infection. Lancet. 344:1994;1671-1673.
38. Mackewicz C.E., Blackbourn D.J., Levy J.A. CD8+ T-cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc. Natl. Acad. Sci. U.S.A. 92:1995;2308-2312.
39. Mackewicz CE, Patterson BK, Lee SA, Levy JA. CD8(+) cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration. J Gen Virol 2000;81 Pt 5:1261-1264.
40. Clerici M., Giorgi J.V., Chou C.C., Gudeman V.K., Zack J.A., Gupta P. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J. Infect. Dis. 165:1992;1012-1019.
41. Fowke K.R., Kaul R., Rosenthal K.L., Oyugi J., Kimani J., Rutherford W.J.et al. HIV-1-specific cellular immune responses among HIV-1-resistant sex workers. Immunol. Cell. Biol. 78:2000;586-595.
42. Klavinskis L.S., Bergmeier L.A., Gao L., Mitchell E., Ward R.G., Layton G.et al. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito- rectal mucosa and draining lymph nodes. J. Immunol. 157:1996;2521-2527.
43. Lehner T., Wang Y., Cranage M., Bergmeier L.A., Mitchell E., Tao L.et al. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat. Med. 2:1996;767-775.
44. Belyakov I.M., Wyatt L.S., Ahlers J.D., Earl P., Pendleton C.D., Kelsall B.L. Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus-expressing human immunodeficiency virus 89.6 envelope protein. J. Virol. 72:1998;8264-8272.
45. McDermott M.R., Bienenstock J. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J. Immunol. 122:1979;1892-1898.
46. Belec L., Meillet D., Gaillard O., Prazuck T., Michel E., Ngondi Ekome J.et al. Decreased cervicovaginal production of both IgA1 and IgA2 subclasses in women with AIDS. Clin. Exp. Immunol. 101:1995;100-106.
47. Belec L., Tevi-Benissan C., Lu X.S., Prazuck T., Pillot J. Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection. AIDS Res. Hum Retroviruses. 11:1995;719-729.
48. Black K.P., Fultz P.N., Girard M., Jackson S. IgA immunity in HIV type 1-infected chimpanzees. II. Mucosal immunity. AIDS Res. Hum. Retroviruses. 13:1997;1273-1282.
49. Buge S.L., Richardson E., Alipanah S., Markham P., Cheng S., Kalyan N.et al. An adenovirus-simian immunodeficiency virus ENV vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge. J. Virol. 71:1997;8531-8541.
50. Bergmeier L.A., Tao L., Gearing A.J., Adams S., Lehner T. Induction of IgA and IgG antibodies in vaginal fluid. Adv. Exp. Med. Biol. 73:1995;1567-1573.
51. Heeney J.L., de Vries P., Dubbes R., Koornstra W., Niphuis H., ten Haaft P.et al. Comparison of protection from homologous cell-free vs. cell-associated SIV challenge afforded by inactivated whole SIV vaccines. J. Med. Primatol. 21:1992;126-130.
52. Osterhaus A., de Vries P., Morein B., Akerblom L., Heeney J. Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted formalin-inactivated SIV vaccines from IV cell-free or cell- associated homologous challenge. AIDS Res. Hum. Retroviruses. 8:1992;1507-1510.
53. Finerty S., Stokes C.R., Gruffydd-Jones T.J., Hillman T.J., Barr F.J., Harbour D.A. Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus. Vaccine. 20:2001;49-58.